The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Session ID: 2025-06-24:936f947c98ce6f73831a607 Player Element ID: V3f69f3ef_05ce_43e7_acbe_c951afabbbb5_6374131301112 ...

A doctor may weigh up the benefits and risks of the flu vaccine for each individual. For some people, it may be safer to get the vaccine, even while sick, to reduce the risk of severe flu and its ...

anti-vaccine After RFK Jr. overhauls CDC panel, measles and flu vaccines are up for debate The new ACIP agenda includes MMRV and thimerosal-containing flu vaccines.

Only the flu vaccine seemed to have a link to lower stroke risk. Dr. de Abajo explained that these results give people yet another reason to get their yearly flu shot.

Until recently, it's likely many people hadn't heard much about the Centers for Disease Control and Prevention's vaccine advisory panel. But the Advisory Committee on Immunization Practices, or ...